{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:27:35Z","timestamp":1782019655412,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Special Fund for Applied Basic Research of Yunnan Provincial Science and Technology Department-Kunming Medical University","award":["202101AY070001-160"],"award-info":[{"award-number":["202101AY070001-160"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160511"],"award-info":[{"award-number":["82160511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Center Climbing Fund","award":["NCC201925B01"],"award-info":[{"award-number":["NCC201925B01"]}]},{"name":"Young and Middle-aged Academic and Technical Leaders Reserve Talent Program of Yunnan Province","award":["202305AC160053"],"award-info":[{"award-number":["202305AC160053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77033-1","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:43:52Z","timestamp":1730105032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Bingyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longguo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enfa","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"key":"77033_CR1","doi-asserted-by":"crossref","unstructured":"Epstein, J.I., et al., Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol, 2017. 41(4): p. e1-e7.","DOI":"10.1097\/PAS.0000000000000820"},{"key":"77033_CR2","doi-asserted-by":"crossref","unstructured":"Epstein, J.I., et al., The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol, 2016. 40(2): p. 244\u201352.","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"5","key":"77033_CR3","first-page":"459","volume":"69","author":"DR Alchin","year":"2017","unstructured":"Alchin, D. R., Murphy, D. & Lawrentschuk, N. Risk factors for Gleason Score upgrading following radical prostatectomy. Minerva Urol Nefrol 69(5), 459\u2013465 (2017).","journal-title":"Minerva Urol Nefrol"},{"issue":"5","key":"77033_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/21681805.2016.1201858","volume":"50","author":"H Samaratunga","year":"2016","unstructured":"Samaratunga, H. et al. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scand J Urol 50(5), 325\u2013329 (2016).","journal-title":"Scand J Urol"},{"issue":"1","key":"77033_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijrobp.2010.11.023","volume":"82","author":"BF Koontz","year":"2012","unstructured":"Koontz, B. F. et al. Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers. Int J Radiat Oncol Biol Phys 82(1), 200\u2013203 (2012).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"77033_CR6","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/j.clgc.2020.02.011","volume":"18","author":"I Lysenko","year":"2020","unstructured":"Lysenko, I. et al. Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis. Clin Genitourin Cancer 18(5), e517\u2013e522 (2020).","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"77033_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5114\/pjp.2022.117174","volume":"73","author":"W Majewski","year":"2022","unstructured":"Majewski, W. et al. Grade migration and important prognostic factors in a pathology specimen for radical radiotherapy in prostate cancer patients. Pol J Pathol 73(1), 27\u201333 (2022).","journal-title":"Pol J Pathol"},{"issue":"1","key":"77033_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ucl.2020.09.010","volume":"48","author":"Y Bhanji","year":"2021","unstructured":"Bhanji, Y., Allaway, M. J. & Gorin, M. A. Recent Advances and Current Role of Transperineal Prostate Biopsy. Urol Clin North Am 48(1), 25\u201333 (2021).","journal-title":"Urol Clin North Am"},{"issue":"3","key":"77033_CR9","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.21037\/tau.2019.09.20","volume":"9","author":"ME Noureldin","year":"2020","unstructured":"Noureldin, M. E. et al. Current techniques of prostate biopsy: an update from past to present. Transl Androl Urol 9(3), 1510\u20131517 (2020).","journal-title":"Transl Androl Urol"},{"issue":"2","key":"77033_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/iju.12660","volume":"22","author":"A Sivaraman","year":"2015","unstructured":"Sivaraman, A. et al. Transperineal template-guided mapping biopsy of the prostate. Int J Urol 22(2), 146\u2013151 (2015).","journal-title":"Int J Urol"},{"issue":"Supp. 1","key":"77033_CR11","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.5152\/tud.2020.20117","volume":"46","author":"M Shah","year":"2020","unstructured":"Shah, M. et al. Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study. Turk J Urol 46(Supp. 1), S27\u2013S39 (2020).","journal-title":"Turk J Urol"},{"issue":"1","key":"77033_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/bju.14477","volume":"123","author":"NC Wong","year":"2019","unstructured":"Wong, N. C. et al. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy. BJU Int 123(1), 51\u201357 (2019).","journal-title":"BJU Int"},{"issue":"4","key":"77033_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/BOR.0000000000000612","volume":"31","author":"JA Walsh","year":"2019","unstructured":"Walsh, J. A. et al. Application of machine learning in the diagnosis of axial spondyloarthritis. Curr Opin Rheumatol 31(4), 362\u2013367 (2019).","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"77033_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/rg.2017160130","volume":"37","author":"BJ Erickson","year":"2017","unstructured":"Erickson, B. J. et al. Machine Learning for Medical Imaging. Radiographics 37(2), 505\u2013515 (2017).","journal-title":"Radiographics"},{"key":"77033_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2022.102289","volume":"128","author":"MM Ahsan","year":"2022","unstructured":"Ahsan, M. M. & Siddique, Z. Machine learning-based heart disease diagnosis: A systematic literature review. Artif Intell Med. 128, 102289 (2022Jun).","journal-title":"Artif Intell Med."},{"issue":"8","key":"77033_CR16","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","volume":"186","author":"K Swanson","year":"2023","unstructured":"Swanson, K. et al. From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell 186(8), 1772\u20131791 (2023).","journal-title":"Cell"},{"issue":"12","key":"77033_CR17","doi-asserted-by":"publisher","first-page":"13099","DOI":"10.2147\/CMAR.S286167","volume":"22","author":"H Liu","year":"2020","unstructured":"Liu, H. et al. Predicting Prostate Cancer Upgrading of Biopsy Gleason Grade Group at Radical Prostatectomy Using Machine Learning-Assisted Decision-Support Models. Cancer Manag Res. 22(12), 13099\u201313110 (2020Dec).","journal-title":"Cancer Manag Res."},{"issue":"13","key":"77033_CR18","doi-asserted-by":"publisher","first-page":"17275","DOI":"10.18632\/oncotarget.7787","volume":"7","author":"B He","year":"2016","unstructured":"He, B. et al. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation. Oncotarget 7(13), 17275\u201317285 (2016).","journal-title":"Oncotarget"},{"issue":"3","key":"77033_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1464-410X.2009.08778.x","volume":"105","author":"AS Moussa","year":"2010","unstructured":"Moussa, A. S. et al. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int 105(3), 352\u2013358 (2010).","journal-title":"BJU Int"},{"issue":"10336","key":"77033_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(22)00367-1","volume":"399","author":"K Fizazi","year":"2022","unstructured":"Fizazi, K. et al. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design. Lancet 399(10336), 1695\u20131707 (2022).","journal-title":"Lancet"},{"key":"77033_CR21","unstructured":"emhadri I, Ruan F, Tibshirani R. LassoNet: Neural Networks with Feature Sparsity. Proc Mach Learn Res. 2021 Apr;130:10\u201318."},{"key":"77033_CR22","doi-asserted-by":"crossref","unstructured":"M RJ, G M, G B, P S. SVM-RFE enabled feature selection with DMN based centroid update model for incremental data clustering using COVID-19. Comput Methods Biomech Biomed Engin. 2023 Jul 24:1\u201315.","DOI":"10.1080\/10255842.2023.2236744"},{"issue":"5123","key":"77033_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.8346439","volume":"261","author":"S Forrest","year":"1993","unstructured":"Forrest, S. Genetic algorithms: principles of natural selection applied to computation. Science 261(5123), 872\u2013878 (1993).","journal-title":"Science"},{"issue":"10","key":"77033_CR24","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.3390\/s22103810","volume":"22","author":"Y Hou","year":"2022","unstructured":"Hou, Y., Gao, H., Wang, Z. & Du, C. Improved Grey Wolf Optimization Algorithm and Application. Sensors (Basel). 22(10), 3810 (2022May 17).","journal-title":"Sensors (Basel)."},{"issue":"6","key":"77033_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287705","volume":"18","author":"T Nguyen","year":"2023","unstructured":"Nguyen, T. et al. SMOTE-CD: SMOTE for compositional data. PLoS One 18(6), e0287705 (2023).","journal-title":"PLoS One"},{"issue":"1","key":"77033_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12859-018-2451-4","volume":"19","author":"H Sanz","year":"2018","unstructured":"Sanz, H. et al. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels. BMC Bioinformatics 19(1), 432 (2018).","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"77033_CR27","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.jtcvs.2020.07.113","volume":"163","author":"H Ishwaran","year":"2022","unstructured":"Ishwaran, H. & O\u2019Brien, R. REPLY: THE STANDARDIZATION AND AUTOMATION OF MACHINE LEARNING FOR BIOMEDICAL DATA. J Thorac Cardiovasc Surg 163(1), e102\u2013e103 (2022).","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"77033_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","volume":"18","author":"JC Stoltzfus","year":"2011","unstructured":"Stoltzfus, J. C. Logistic regression: a brief primer. Acad Emerg Med 18(10), 1099\u20131104 (2011).","journal-title":"Acad Emerg Med"},{"issue":"1","key":"77033_CR29","first-page":"41","volume":"15","author":"S Huang","year":"2018","unstructured":"Huang, S. et al. Applications of Support Vector Machine (SVM) Learning in Cancer Genomics. Cancer Genomics Proteomics 15(1), 41\u201351 (2018).","journal-title":"Cancer Genomics Proteomics"},{"key":"77033_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4419-7046-6_19","volume":"696","author":"D Che","year":"2011","unstructured":"Che, D., Liu, Q., Rasheed, K. & Tao, X. Decision tree and ensemble learning algorithms with their applications in bioinformatics. Adv Exp Med Biol. 696, 191\u2013199 (2011).","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"77033_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","volume":"47","author":"SJ Rigatti","year":"2017","unstructured":"Rigatti, S. J. Random Forest. J Insur Med 47(1), 31\u201339 (2017).","journal-title":"J Insur Med"},{"key":"77033_CR32","unstructured":"Tianqi, C. and G. Carlos, XGBoost: A Scalable Tree Boosting System. CoRR, 2016. abs\/1603.02754."},{"issue":"6","key":"77033_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/s19061476","volume":"19","author":"K Li","year":"2019","unstructured":"Li, K., Zhou, G., Zhai, J., Li, F. & Shao, M. Improved PSO_AdaBoost Ensemble Algorithm for Imbalanced Data. Sensors (Basel). 19(6), 1476 (2019Mar 26).","journal-title":"Sensors (Basel)."},{"issue":"7","key":"77033_CR34","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1016\/j.cub.2019.02.034","volume":"29","author":"N Kriegeskorte","year":"2019","unstructured":"Kriegeskorte, N. & Golan, T. Neural network models and deep learning. Curr Biol 29(7), R231\u2013R236 (2019).","journal-title":"Curr Biol"},{"key":"77033_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neunet.2021.12.016","volume":"147","author":"J Zeng","year":"2022","unstructured":"Zeng, J., Zhang, M. & Lin, S. B. Fully corrective gradient boosting with squared hinge: Fast learning rates and early stopping. Neural Netw. 147, 136\u2013151 (2022Mar).","journal-title":"Neural Netw."},{"issue":"4","key":"77033_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1213\/ANE.0000000000002370","volume":"125","author":"TR Vetter","year":"2017","unstructured":"Vetter, T. R. Fundamentals of Research Data and Variables: The Devil Is in the Details. Anesth Analg 125(4), 1375\u20131380 (2017).","journal-title":"Anesth Analg"},{"issue":"5","key":"77033_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/pst.1628","volume":"13","author":"H Li","year":"2014","unstructured":"Li, H. & Johnson, T. Wilcoxon\u2019s signed-rank statistic: what null hypothesis and why it matters. Pharm Stat 13(5), 281\u2013285 (2014).","journal-title":"Pharm Stat"},{"issue":"5","key":"77033_CR38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ajodo.2016.08.009","volume":"150","author":"N Pandis","year":"2016","unstructured":"Pandis, N. The chi-square test. Am J Orthod Dentofacial Orthop 150(5), 898\u2013899 (2016).","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"1","key":"77033_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm, F. S. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1), 25\u201336 (2022).","journal-title":"Korean J Anesthesiol"},{"issue":"9","key":"77033_CR40","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00439-021-02402-z","volume":"141","author":"AM Musolf","year":"2022","unstructured":"Musolf, A. M. et al. What makes a good prediction? Feature importance and beginning to open the black box of machine learning in genetics. Hum Genet 141(9), 1515\u20131528 (2022).","journal-title":"Hum Genet"},{"key":"77033_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-98253-9_20","volume-title":"Fusion-Based Head and Neck Tumor Segmentation and Survival Prediction Using Robust Deep Learning Techniques and Advanced Hybrid Machine Learning Systems","author":"M Fatan","year":"2022","unstructured":"Fatan, M. et al. Fusion-Based Head and Neck Tumor Segmentation and Survival Prediction Using Robust Deep Learning Techniques and Advanced Hybrid Machine Learning Systems (Springer International Publishing, 2022)."},{"issue":"4","key":"77033_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2021.752558","volume":"17","author":"A Gramegna","year":"2021","unstructured":"Gramegna, A. & Giudici, P. SHAP and LIME: An Evaluation of Discriminative Power in Credit Risk. Front Artif Intell. 17(4), 752558 (2021Sep).","journal-title":"Front Artif Intell."},{"issue":"4","key":"77033_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/jcm8040438","volume":"8","author":"DY Chung","year":"2019","unstructured":"Chung, D. Y. et al. Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6\u207b7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8\u207b10. J Clin Med. 8(4), 438 (2019Mar 30).","journal-title":"J Clin Med."},{"issue":"12","key":"77033_CR44","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00330-014-3367-7","volume":"24","author":"T Gondo","year":"2014","unstructured":"Gondo, T. et al. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer. Eur Radiol 24(12), 3161\u20133170 (2014).","journal-title":"Eur Radiol"},{"issue":"18","key":"77033_CR45","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Bill-Axelson","year":"2011","unstructured":"Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364(18), 1708\u20131717 (2011).","journal-title":"N Engl J Med"},{"issue":"8","key":"77033_CR46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams, I. S. et al. Modern paradigms for prostate cancer detection and management. Med J Aust 217(8), 424\u2013433 (2022).","journal-title":"Med J Aust"},{"issue":"2","key":"77033_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.29271\/jcpsp.2023.02.193","volume":"33","author":"E Sogutdelen","year":"2023","unstructured":"Sogutdelen, E. & Citamak, B. Is Low-risk Prostate Cancer Really Low-risk? Consider Factors Affecting Biochemical Recurrence and Tumour Upgrade. J Coll Physicians Surg Pak 33(2), 193\u2013198 (2023).","journal-title":"J Coll Physicians Surg Pak"},{"issue":"12","key":"77033_CR48","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1464-410X.2011.10809.x","volume":"109","author":"R Kirby","year":"2012","unstructured":"Kirby, R. & Fitzpatrick, J. M. Optimising repeat prostate biopsy decisions and procedures. BJU Int 109(12), 1750\u20131754 (2012).","journal-title":"BJU Int"},{"issue":"1","key":"77033_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bju.15065","volume":"126","author":"DF Osses","year":"2020","unstructured":"Osses, D. F. et al. Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?. BJU Int 126(1), 124\u2013132 (2020).","journal-title":"BJU Int"},{"issue":"8","key":"77033_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrurol.2015.159","volume":"12","author":"MJ Blute","year":"2015","unstructured":"Blute, M. J. et al. Addressing the need for repeat prostate biopsy: new technology and approaches. Nat Rev Urol 12(8), 435\u2013444 (2015).","journal-title":"Nat Rev Urol"},{"issue":"6","key":"77033_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267714","volume":"17","author":"M Mokoatle","year":"2022","unstructured":"Mokoatle, M. et al. Discriminatory Gleason grade group signatures of prostate cancer: An application of machine learning methods. PLoS One 17(6), e0267714 (2022).","journal-title":"PLoS One"},{"issue":"2","key":"77033_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten, W. et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol 21(2), 233\u2013241 (2020).","journal-title":"Lancet Oncol"},{"issue":"4","key":"77033_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/diagnostics9040219","volume":"9","author":"O Hamzeh","year":"2019","unstructured":"Hamzeh, O. et al. A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer. Diagnostics (Basel). 9(4), 219 (2019Dec 11).","journal-title":"Diagnostics (Basel)."},{"issue":"4","key":"77033_CR54","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.juro.2011.05.082","volume":"186","author":"H Botto","year":"2011","unstructured":"Botto, H. et al. High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone. J Urol 186(4), 1400\u20131405 (2011).","journal-title":"J Urol"},{"issue":"11","key":"77033_CR55","first-page":"6137","volume":"35","author":"M Shiota","year":"2015","unstructured":"Shiota, M. et al. Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng\/ml. Anticancer Res 35(11), 6137\u20136145 (2015).","journal-title":"Anticancer Res"},{"issue":"5","key":"77033_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4149\/gpb_2017044","volume":"36","author":"H Drobkova","year":"2017","unstructured":"Drobkova, H. et al. Testosterone as a prospective predictor of pathological Gleason score and pathological stage in prostate cancer. Gen Physiol Biophys 36(5), 549\u2013556 (2017).","journal-title":"Gen Physiol Biophys"},{"issue":"6","key":"77033_CR57","first-page":"471","volume":"19","author":"P Pepe","year":"2015","unstructured":"Pepe, P. & Pennisi, M. Gleason score stratification according to age at diagnosis in 1028 men. Contemp Oncol (Pozn) 19(6), 471\u2013473 (2015).","journal-title":"Contemp Oncol (Pozn)"},{"issue":"12","key":"77033_CR58","doi-asserted-by":"publisher","first-page":"1072437","DOI":"10.3389\/fonc.2022.1072437","volume":"7","author":"B Li","year":"2022","unstructured":"Li, B. et al. Diagnostic performance of 99mTc-HYNIC-PSMA SPECT\/CT for biochemically recurrent prostate cancer after radical prostatectomy. Front Oncol. 7(12), 1072437 (2022Dec).","journal-title":"Front Oncol."},{"issue":"5","key":"77033_CR59","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4103\/jcrt.jcrt_1719_21","volume":"19","author":"E Rani","year":"2023","unstructured":"Rani, E., Nibhoria, S. & Nagpal, N. Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: A study in a tertiary care hospital. J Cancer Res Ther 19(5), 1305\u20131310 (2023).","journal-title":"J Cancer Res Ther"},{"issue":"3\u20134","key":"77033_CR60","first-page":"553","volume":"38","author":"AA Elabbady","year":"2006","unstructured":"Elabbady, A. A. & Khedr, M. M. Free\/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3\u201310 ng\/ml. Int Urol Nephrol 38(3\u20134), 553\u2013557 (2006).","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"77033_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.29271\/jcpsp.2020.04.399","volume":"30","author":"MC Temel","year":"2020","unstructured":"Temel, M. C. et al. Association of Gleason score with PSA Values and Serum Testosterone Levels Measured Prior To Prostate Biopsy. J Coll Physicians Surg Pak 30(4), 399\u2013402 (2020).","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"77033_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1590\/S1677-55382008000100005","volume":"34","author":"MS Guimaraes","year":"2008","unstructured":"Guimaraes, M. S. et al. Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy. Int Braz J Urol 34(1), 23\u201329 (2008).","journal-title":"Int Braz J Urol"},{"issue":"10","key":"77033_CR63","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/pros.22985","volume":"75","author":"K Izumi","year":"2015","unstructured":"Izumi, K. et al. The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels. Prostate 75(10), 1034\u20131042 (2015).","journal-title":"Prostate"},{"key":"77033_CR64","doi-asserted-by":"crossref","unstructured":"Edge, S.B. and C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010. 17(6): p. 1471\u20134.","DOI":"10.1245\/s10434-010-0985-4"},{"issue":"23","key":"77033_CR65","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.12659\/MSM.900977","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma. Med Sci Monit. 12(23), 1768\u20131774 (2017Apr).","journal-title":"Med Sci Monit."},{"issue":"5","key":"77033_CR66","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3349\/ymj.2015.56.5.1206","volume":"56","author":"KC Koo","year":"2015","unstructured":"Koo, K. C. et al. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer. Yonsei Med J 56(5), 1206\u20131212 (2015).","journal-title":"Yonsei Med J"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77033-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:52:43Z","timestamp":1730105563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77033-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77033"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77033-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Yunnan Cancer Hospital Ethics Committee. All methods were carried out in accordance with relevant guidelines and regulations. All recipients signed informed consent and for dead patients informed consent from legal guardians\/next of kin were obtained.(The project review number is KYLX2024-011, and the project ethics acceptance number is SLKYLX2024-011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all patients involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"25641"}}